In vivo, CD8+CD38high, but not CD8+CD38− T cells mitigate murine experimental autoimmune encephalomyelitis (EAE) by reducing the clinical score and delaying disease occurrence. The gene discussed is CD8A; the disease is experimental autoimmune encephalomyelitis.